Management team
Dr. Christof Böhler, Chief Executive Officer
After finishing his PhD in chemistry at ETH Zurich dealing with bio-polymeric drug release systems, Christof moved to the United States for a Postdoc at the Salk and Scripps Research Institutes in La Jolla (CA, USA) carrying out bio-medical basic research. From there he started to work as the head of development for a start up biotech company in Zurich, whose process has now been commercialized. Realizing the need to develop his commercial know-how, he moved into product management of research chemicals and biologicals at Fluka Chemie AG (a Sigma Aldrich company, Buchs, CH). During his Fluka time he completed a postgraduate executive degree in "International Management" at the FH Liechtenstein and UBC Vancouver (Canada). His further career involved Business Development Manager Europe and Business Manager for Maybridge, a Drug Discovery service company, and finally Marketing Director "Drug Discovery Chemicals" for Acros/Maybridge (Fisher Scientific). Christof brings into the company excellent knowledge in the bio-medical sector, proven hands on commercial skills, as well as a global network of key decision makers in the pharmaceutical and biotech industries.
|
 |
|
Thomas Bragagna, Chief Technology Officer
After finishing his apprenticeship in Austria specializing in
audio electronics Thomas realised his talent not only as
an electronic engineer, but also as a men manager. At a
Swiss based company he advanced his electronics
knowledge in high power electronics and in parallel he built
up a logistics department with finally 13 employees. From
that company he moved to Pantec Engineering, a high-tech
company in Liechtenstein working initially as a test field
engineer, later as an application engineer and then as
head of the department Electronic Systems.
He also is in constant training at various universities to
keep up with the fast-track development. His efforts, his
innovative mind and his unbroken will to succeed yielded
him the leading technical management position within
Pantec Biosolutions. There he led his team to complete
the development of the world's smallest and most efficient
mid-IR lasers and laser diode drivers in only three years.
His current main task is to shift device development to
high volume production. Thomas brings into the company
excellent general engineering and management skills as
well as major experience in innovation management and
in the generation of intellectual property.
|
 |
Dr. Norbert Clemens, Clinical Director, as permanent Consultant
Dr. Norbert Clemens is the company’s permanent Clinical Consultant and the phase III specialist of the CRS-Group. After gaining his MD in 1987 and PhD three years later from the Ruhr-University of Bochum, Germany, Dr. Clemens pursued a successful academic career in a number of positions, including a year as an AIDS researcher in the public health service. His introduction to the pharmaceutical industry was as a project manager at Intersan GmbH, a subsidiary of the IPSEN group, where he had responsibilities across several therapeutic areas including endocrinology, neurology, dermatology and gastroenterology. Dr. Clemens was Medical Director of Intersan/Ipsen Pharma and of the biotech company PAION for several years. Furthermore, he was Medical Director R & D at Valeant Pharmaceuticals International (previously ICN Pharmaceuticals) in Switzerland as well as General Manager and Head Global Clinical Trial Services at Analytica International GmbH in Germany. He is now Head of Clinical Development at CRS Mannheim, Germany. Dr. Clemens maintains a visible presence in European pharmaceutical circles: he has been a board member of the R&D section of the German Association of the Pharmaceutical Industry (BPI) for several years and is a member of the drug safety and educational commissions. |
|
|
 |
